Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H43NO6 |
Molecular Weight | 465.6227 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCC(O)=O
InChI
InChIKey=RFDAIACWWDREDC-FRVQLJSFSA-N
InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1
Molecular Formula | C26H43NO6 |
Molecular Weight | 465.6227 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 11 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28942640
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28942640
Glycocholic acid (GCA) is an important metabolite of bile acids, a conjugate of cholic acid with glycine. GCA urine levels are expected to be a specific diagnostic biomarker for hepatocellular carcinoma (HCC). The average GCA concentrations of HCC patients in plasma and urine were about 25 and 2.8 times than that of healthy volunteers.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The lung as a route for systemic delivery of therapeutic proteins and peptides. | 2001 |
|
Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol. | 2001 Aug |
|
MRP subfamily transporters and resistance to anticancer agents. | 2001 Dec |
|
Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. | 2001 Mar |
|
Analysis of the physicochemical interactions between Clostridium difficile toxins and cholestyramine using liquid chromatography with post-column derivatization. | 2001 Mar 9 |
|
Pericentral hepatocytes translocate hydrophilic bile acids more rapidly than hydrophobic ones. | 2001 Oct |
|
Solubilization of drugs by physiological mixtures of bile salts. | 2002 Aug |
|
Maldigestion and malabsorption of dietary lipid during severe childhood malnutrition. | 2002 Dec |
|
Drug metabolic activity of cultured hepatocytes can synchronize with bile acid concentration in the medium. | 2002 Mar |
|
Colesevelam hydrochloride. | 2002 May 15 |
|
[Relationship of vascular endothelial growth factor with bile acid in intrahepatic cholestasis of pregnancy]. | 2002 Nov |
|
Ion conductors derived from biogenic amines, bile acids, and amino acids. | 2002 Nov-Dec |
|
[Relationship between human leukocyte antigen-DRB1 allele gene polymorphism and intrahepatic cholestasis of pregnancy]. | 2002 Sep |
|
[Comparative characteristics of lipid components of gallbladder and liver bile fractions in children with chronic cholecystitis]. | 2003 |
|
Differential effects of metformin on bile salt absorption from the jejunum and ileum. | 2003 Mar |
|
Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. | 2003 May |
|
Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats. | 2003 Nov |
|
Functional assessment of bacterial colonization in patients with ileal pouch-anal anastomosis and Brooke ileostomy. | 2004 Aug |
|
Biquinolino-modified beta-cyclodextrin dimers and their metal complexes as efficient fluorescent sensors for the molecular recognition of steroids. | 2004 Aug 6 |
|
Alkanoylsucroses in nasal delivery of low molecular weight heparins: in-vivo absorption and reversibility studies in rats. | 2004 Jan |
|
Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump. | 2005 Jan |
|
Stable ciliary activity in human nasal epithelial cells grown in a perfusion system. | 2005 Mar 23 |
|
Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. | 2005 Oct 3 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:17:28 GMT 2023
by
admin
on
Fri Dec 15 15:17:28 GMT 2023
|
Record UNII |
G59NX3I3RT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C843
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
||
|
LOINC |
2100-6
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
||
|
CFR |
21 CFR 862.1177
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
G59NX3I3RT
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
10140
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
SUB22781
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
C77849
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
17687
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
DTXSID2047436
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
1426482
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB02691
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
D006000
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
100000088797
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
GLYCOCHOLIC ACID
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
G59NX3I3RT
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
475-31-0
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
207-494-9
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | |||
|
m5799
Created by
admin on Fri Dec 15 15:17:28 GMT 2023 , Edited by admin on Fri Dec 15 15:17:28 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
LABELED -> NON-LABELED |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |